| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.93B | 3.95B | 4.05B | 5.87B | 5.19B | 3.10B |
| Gross Profit | 939.52M | 1.16B | 1.06B | 2.12B | 2.34B | 1.13B |
| EBITDA | 444.92M | 693.50M | 597.02M | 1.51B | 1.72B | 743.82M |
| Net Income | 405.51M | 482.28M | 400.67M | 1.16B | 1.29B | 502.63M |
Balance Sheet | ||||||
| Total Assets | 7.32B | 7.20B | 7.03B | 7.08B | 7.62B | 6.78B |
| Cash, Cash Equivalents and Short-Term Investments | 282.75M | 290.66M | 263.67M | 421.70M | 324.88M | 422.68M |
| Total Debt | 487.74M | 653.06M | 678.91M | 746.46M | 1.04B | 1.54B |
| Total Liabilities | 1.08B | 1.26B | 1.23B | 1.44B | 2.04B | 2.34B |
| Stockholders Equity | 6.23B | 5.94B | 5.80B | 5.63B | 5.57B | 4.44B |
Cash Flow | ||||||
| Free Cash Flow | 293.95M | 282.02M | 142.21M | 955.86M | 762.12M | 348.55M |
| Operating Cash Flow | 741.42M | 1.06B | 756.45M | 1.57B | 1.43B | 827.06M |
| Investing Cash Flow | -760.78M | -826.47M | -613.69M | -610.62M | -636.18M | -476.20M |
| Financing Cash Flow | -242.78M | -265.43M | -298.37M | -840.28M | -919.87M | -253.94M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | HK$1.21B | 16.88 | 3.61% | 1.85% | -8.51% | -68.34% | |
69 Neutral | HK$4.08B | 7.18 | 9.36% | 6.82% | -3.73% | 6.09% | |
64 Neutral | HK$2.78B | 3.69 | 13.87% | ― | 9.20% | 213.87% | |
62 Neutral | HK$16.23B | 11.74 | 10.43% | 0.93% | -1.43% | 113.67% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
54 Neutral | HK$10.29B | -145.28 | -0.52% | 1.06% | -15.17% | -125.24% | |
54 Neutral | HK$1.22B | 18.94 | 2.46% | 3.68% | -5.29% | -32.47% |
Lee & Man Chemical Co. Ltd. has released a supplemental announcement regarding its 2024 Annual Report, providing additional information on its Share Option Scheme. The company has fully utilized the scheme mandate, with no options available for grant as of January 1 and December 31, 2024. The scheme allows participation from directors, employees, and various stakeholders who contribute to the group. The total shares available for issue under the scheme represent 10% of the total issued shares. This announcement ensures compliance with the Listing Rules and clarifies the operational aspects of the Share Option Scheme, potentially impacting stakeholders’ engagement with the company.
The most recent analyst rating on (HK:0746) stock is a Buy with a HK$5.50 price target. To see the full list of analyst forecasts on Lee & Man Chemical Co. Ltd. stock, see the HK:0746 Stock Forecast page.
Lee & Man Chemical Co. Ltd. has announced a connected transaction involving the transfer of land use rights in Changshu, China. Jiangsu Paper and Jiangsu Chemical, subsidiaries of Lee & Man Paper and Lee & Man Chemical respectively, have entered into a contract for the transfer of these rights for approximately RMB67.53 million. This transaction, categorized under Chapter 14A of the Listing Rules, is subject to reporting and announcement requirements but is exempt from shareholder approval. The land, designated for industrial use, spans approximately 74,937 square meters, and the payment will be made in three installments.
Lee & Man Chemical Co. Ltd. has announced the forfeiture of unclaimed dividends from 2018 and 2019, which will revert to the company if not claimed by September 15, 2025. Shareholders are advised to contact the company’s registrar to claim their dividends, highlighting the company’s adherence to its Articles of Association and impacting shareholder relations.
Lee & Man Chemical Company Limited reported a significant 36% increase in profit to HK$327 million for the first half of 2025, driven by reduced energy costs and lower raw material prices. The company’s gross profit margin improved by 7.4 percentage points to 36.3%, and it proposed an interim dividend of HK19.5 cents per share, up from HK14 cents in the previous year, indicating strong financial performance and positive implications for stakeholders.
Lee & Man Chemical Co. Ltd. has announced an interim cash dividend of HKD 0.195 per share for the six months ended 30 June 2025, with the payment date set for 09 September 2025. This announcement reflects the company’s financial performance and commitment to returning value to shareholders, potentially enhancing its market position and stakeholder confidence.